Release Date: 02/07/18 14:09 Summary: Notice of Extraordinary General Meeting/Proxy Form Price Sensitive: No Download Document 479.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%